Dengue Research Opportunities in the AmericasLAUGHLIN, Catherine A; MORENS, David M; CASSETTI, M. Cristina et al.The Journal of infectious diseases. 2012, Vol 206, Num 7, pp 1121-1127, issn 0022-1899, 7 p.Article

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancyWRIGHT, Peter F; KARRON, Ruth A; WITTEK, Alec E et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1331-1342, issn 0022-1899Article

A Novel Approach for the Rapid Mutagenesis and Directed Evolution of the Structural Genes of West Nile VirusLIN, Tsai-Yu; DOWD, Kimberly A; MANHART, Carolyn J et al.Journal of virology. 2012, Vol 86, Num 7, pp 3501-3512, issn 0022-538X, 12 p.Article

Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin : a retrospective studyJONES, Kevin F; WHITEHEAD, Stephen S; CUNNINGHAM, Madeleine W et al.Infection and immunity. 2000, Vol 68, Num 12, pp 7132-7136, issn 0019-9567Article

Dengue Vaccine Candidates in DevelopmentDURBIN, Anna P; WHITEHEAD, Stephen S.Current Topics in Microbiology and Immunology. 2010, Vol 338, pp 129-143, issn 0070-217X, 15 p.Article

Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick- borne Langat virus does not alter vector specificityTUMBAN, Ebenezer; MITZEL, Dana N; MAES, Nyree E et al.Journal of general virology. 2011, Vol 92, pp 841-848, issn 0022-1317, 8 p., 4Article

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult VolunteersWRIGHT, Peter F; DURBIN, Anna P; MURPHY, Brian R et al.The American journal of tropical medicine and hygiene. 2009, Vol 81, Num 5, pp 834-841, issn 0002-9637, 8 p.Article

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeysBLANEY, Joseph E; MATRO, Jennifer M; MURPHY, Brian R et al.Journal of virology. 2005, Vol 79, Num 9, pp 5516-5528, issn 0022-538X, 13 p.Article

Genetically modified, live attenuated dengue virus type 3 vaccine candidatesBLANEY, Joseph E; HANSON, Christopher T; FIRESTONE, Cai-Yen et al.The American journal of tropical medicine and hygiene. 2004, Vol 71, Num 6, pp 811-821, issn 0002-9637, 11 p.Article

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical TrialDURBIN, Anna P; KIRKPATRICK, Beth D; HYNES, Noreen A et al.The Journal of infectious diseases. 2013, Vol 207, Num 6, pp 957-965, issn 0022-1899, 9 p.Article

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccineDURBIN, Anna P; KIRKPATRICK, Beth D; PIERCE, Kristen K et al.Vaccine. 2011, Vol 29, Num 42, pp 7242-7250, issn 0264-410X, 9 p.Article

Targeted Mutagenesis as a Rational Approach to Dengue Virus Vaccine DevelopmentBLANEY, Joseph E; DURBIN, Anna P; MURPHY, Brian R et al.Current Topics in Microbiology and Immunology. 2010, Vol 338, pp 145-158, issn 0070-217X, 14 p.Article

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4BLANEY, Joseph E; SATHE, Neeraj S; GODDARD, Laura et al.Vaccine. 2008, Vol 26, Num 6, pp 817-828, issn 0264-410X, 12 p.Article

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4GROMOWSKI, Gregory D; FIRESTONE, Cai-Yen; HANSON, Christopher T et al.Vaccine. 2014, Vol 32, Num 25, pp 3010-3018, issn 0264-410X, 9 p.Article

Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar CharacteristicsSMITH, Scott A; DE ALWIS, Ruklanthi; KOSE, Nurgun et al.The Journal of infectious diseases. 2013, Vol 207, Num 12, pp 1898-1908, issn 0022-1899, 11 p.Article

Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profilesLINDOW, Janet C; DURBIN, Anna P; WHITEHEAD, Stephen S et al.Vaccine. 2013, Vol 31, Num 33, pp 3347-3352, issn 0264-410X, 6 p.Article

The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteersDURBIN, Anna P; WRIGHT, Peter F; COX, Amber et al.Vaccine. 2013, Vol 31, Num 48, pp 5772-5777, issn 0264-410X, 6 p.Article

rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. CommentaryDURBIN, Anna P; WHITEHEAD, Stephen S; MCARTHUR, Julie et al.The Journal of infectious diseases. 2005, Vol 191, Num 5, pp 710-718, issn 0022-1899, 13 p.Article

Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunityHANLEY, Kathryn A; MANLUCU, Luella R; MANIPON, Gracielle G et al.Vaccine. 2004, Vol 22, Num 25-26, pp 3440-3448, issn 0264-410X, 9 p.Article

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated regionDURBIN, Anna P; KARRON, Ruth A; CHANOCK, Robert M et al.The American journal of tropical medicine and hygiene. 2001, Vol 65, Num 5, pp 405-413, issn 0002-9637Article

Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is EndemicDURBIN, Anna P; SCHMIDT, Alexander; ELWOOD, Dan et al.The Journal of infectious diseases. 2011, Vol 203, Num 3, pp 327-334, issn 0022-1899, 8 p.Article

Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysBLANEY, Joseph E; SPEICHER, James; HANSON, Christopher T et al.Vaccine. 2008, Vol 26, Num 33, pp 4150-4159, issn 0264-410X, 10 p.Article

Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersWRIGHT, Peter F; ANKRAH, Sharon; HENDERSON, Susan E et al.Vaccine. 2008, Vol 26, Num 7, pp 882-890, issn 0264-410X, 9 p.Article

Phase I Clinical Evaluation of rDEN4A30-200,201 : A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased HepatotoxicityMCARTHUR, Julie H; DURBIN, Anna P; MARRON, Jennifer A et al.The American journal of tropical medicine and hygiene. 2008, Vol 79, Num 5, pp 678-684, issn 0002-9637, 7 p.Article

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cellsBLANEY, Joseph E; MANIPON, Gracielle G; FIRESTONE, Cai-Yen et al.Vaccine. 2003, Vol 21, Num 27-30, pp 4317-4327, issn 0264-410X, 11 p.Article